Streetbeat News

Products Services

DELL

Dell Technologies Inc (NYSE:DELL) reported Q1 earnings with revenue of $22.24 billion, beating estimates. Despite strong performance in AI-optimized servers, shares fell 12.93% in after-hours trading.

Portfolio Pulse from Adam Eckert

May 30, 2024 | 8:31 pm

AMD

NVDA

The U.S. government has temporarily halted the export of AI chips to the Middle East, affecting companies like Nvidia (NVDA) and AMD (AMD). This decision is part of a national security review to prevent advanced semiconductors from reaching China through Middle Eastern data centers.

Portfolio Pulse from Michael Cohen

May 30, 2024 | 8:30 pm

MYGN

QGEN

QIAGEN and Myriad Genetics have announced a collaboration to develop a globally distributable kit-based test for analyzing Homologous Recombination Deficiency (HRD) status.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:30 pm

VFC

VF Corporation has appointed Michelle Choe as the Global Brand President of Vans, effective late July. This leadership change is expected to bring new strategic direction to the Vans brand.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:22 pm

ADAP

Adaptimmune Therapeutics shares are trading higher after the company and Galapagos entered a clinical collaboration to license Adaptimmune's uza-cel in head & neck cancer.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:17 pm

VST

Vistra (NYSE:VST) plans to add up to 2,000 MW of gas-fueled dispatchable power in Texas, including new plants, repowering a retired coal plant, and upgrading existing gas plants.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:04 pm

ADAP

GLPG

Adaptimmune and Galapagos have entered a clinical collaboration to license next-generation TCR T-cell therapy for cancer using a decentralized manufacturing platform. The collaboration will focus on a clinical proof-of-concept trial for uza-cel in head & neck cancer. Adaptimmune will receive initial payments of $100 million, with potential additional payments up to $565 million.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:02 pm

RARE

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced positive topline results from its Phase 3 study of DTX401 gene therapy for Glycogen Storage Disease Type Ia. The study showed a significant reduction in daily cornstarch intake and maintained glucose control, achieving its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:01 pm

MSFT

SONY

In April, the US gaming market saw a 3% drop in consumer spending, totaling $4.1 billion. Despite this, game content spending rose by 2% to $3.7 billion. Hardware sales plummeted by 43% to $208 million, with Sony's PlayStation 5 leading sales, followed by Nintendo Switch and Microsoft's Xbox. Notable software performances included Stellar Blade and Sea of Thieves.

Portfolio Pulse from Franca Quarneti

May 30, 2024 | 7:58 pm

EXPE

Expedia Group and KOALA have announced a partnership to streamline timeshare rentals through Expedia's network, including Vrbo. KOALA's new software will allow timeshare owners and brokers to reach a vast audience, simplifying the rental process.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 7:58 pm